Professor Erik Fosse from The Intervention Centre at the Division of Diagnostics and Intervention, OUS, is awarded the University of Oslo Innovation prize for his creations within the fields of medicine and health service.
Fosse will receive the prize at a seremony taking place during the annual party for the University of Oslo September 2nd.
Published in major journals, first or last author from Oslo University Hospital.
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Lancet, 385 (9978), 1653-61
Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis
Gastroenterology, 148 (5), 924-927.e2
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
Hepatology, 61 (5), 1651-9